CMS’s new GLP-1 Bridge program expands Medicare access to obesity drugs but raises concerns about cost, supply and implementation challenges. The post Does CMS Know What It Is Doing With Its GLP-1 Obesity Coverage Pilot? appeared first on MedCity News.
AstraZeneca is getting rights to a Sino Biopharmaceutical drug that offers a dual mechanism to treat chronic obstructive pulmonary disease, or COPD. It’s the same approach as an FDA-approved drug that Merck acquired last year in a multi-billion dollar deal. The post AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug…
The honest question is not whether AI will end the fight. It will not. The honest question is what AI does to a fight that has been structurally imbalanced for 30 years. The post Prior Authorization is a Fight and AI Won’t End It — Stop Pretending Otherwise appeared first on MedCity News.
For many of Medicaid’s highest-need members, the problem isn’t that services don’t exist. It’s that the system can’t consistently reach the people who need those services most. The post Medicaid’s Next Performance Test: Can Plans Reach the Members They’re Accountable For? appeared first on MedCity News.
To truly deliver on the promise of proactive, preventive care for seniors with complex, chronic conditions, we should move away from the current one-year open enrollment cycle and toward a five-year contract period. The post Stop the Revolving Door: Why Five-Year Contracts are the Key to Saving Medicare Advantage appeared first on MedCity News.
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the health risks of consuming raw milk and an outbreak of infant botulism linked to recalled formula on CBS News’ CBS Mornings and CBS News 24/7’s The Daily Report on July 7. Gounder also discussed allegations about Health and Human Services Secretary Robert F. Kennedy…
Handspring raised $19 million in Series B funding this week to expand its pediatric mental health care model nationwide. The company treats the full spectrum of acuity so children are matched to the level of care they actually need, rather than defaulting to the most intensive — and expensive — option available. The post Handspring…
UnitedHealthcare introduced a Lifestyle Spending Account that gives employers more flexibility to fund employees’ health and wellness expenses. The post UHC Unveils New Employer-Sponsored Spending Account Benefit appeared first on MedCity News.
A Bausch + Lomb drug from a 2025 acquisition missed primary and secondary goals of a Phase 2 test in glaucoma. Bausch now plans to develop this drug for geographic atrophy, aiming to succeed where Allergan, now an AbbVie subsidiary, fell short in the clinic. The post Glaucoma Drug Fails Trial, But Bausch + Lomb…
Despite ongoing improvement, stakeholders highlight need to modernize how accountable care models are evaluated